Papillary thyroid carcinoma with tall cell features is as aggressive as tall cell variant: a meta-analysis
There are still ongoing debates as to which cut-off percentage of tall cell (TC) should be used to define tall cell variant (TCV) papillary thyroid carcinoma (PTC). In this meta-analysis, we aimed to investigate the clinicopathological significance of PTC with tall cell features (PTC-TCF, PTC with 1...
Main Authors: | , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Bioscientifica
2018-11-01
|
Series: | Endocrine Connections |
Subjects: | |
Online Access: | https://ec.bioscientifica.com/view/journals/ec/7/12/EC-18-0333.xml |
id |
doaj-76e3f9bb50f6420292192f2f273b4ec9 |
---|---|
record_format |
Article |
spelling |
doaj-76e3f9bb50f6420292192f2f273b4ec92020-11-25T00:39:14ZengBioscientificaEndocrine Connections2049-36142049-36142018-11-01712R286R293https://doi.org/10.1530/EC-18-0333Papillary thyroid carcinoma with tall cell features is as aggressive as tall cell variant: a meta-analysisHuy Gia Vuong0Nguyen Phuoc Long1Nguyen Hoang Anh2Tran Diem Nghi3Mai Van Hieu4Le Phi Hung5Tadao Nakazawa6Ryohei Katoh7Tetsuo Kondo8Department of Pathology, University of Yamanashi, Yamanashi, JapanFaculty of Medicine, University of Medicine and Pharmacy at Ho Chi Minh City, Ho Chi Minh City, Viet NamSchool of Medicine, Viet Nam National University, Ho Chi Minh City, Viet NamSchool of Medicine, Viet Nam National University, Ho Chi Minh City, Viet NamSchool of Medicine, Viet Nam National University, Ho Chi Minh City, Viet NamFaculty of Medicine, University of Medicine and Pharmacy at Ho Chi Minh City, Ho Chi Minh City, Viet NamDepartment of Pathology, University of Yamanashi, Yamanashi, JapanDepartment of Pathology, University of Yamanashi, Yamanashi, JapanDepartment of Pathology, University of Yamanashi, Yamanashi, JapanThere are still ongoing debates as to which cut-off percentage of tall cell (TC) should be used to define tall cell variant (TCV) papillary thyroid carcinoma (PTC). In this meta-analysis, we aimed to investigate the clinicopathological significance of PTC with tall cell features (PTC-TCF, PTC with 10–50% of TCs) in comparison with classical PTC and TCVPTC (PTC with more than 50% of TCs) to clarify the controversial issue. Four electronic databases including PubMed, Web of Science, Scopus and Virtual Health Library were accessed to search for relevant articles. We extracted data from published studies and pooled into odds ratio (OR) and its corresponding 95% confidence intervals (CIs) using random-effect modeling. Nine studies comprising 403 TCVPTCs, 325 PTC-TCFs and 3552 classical PTCs were included for meta-analyses. Overall, the clinicopathological profiles of PTC-TCF including multifocality, extrathyroidal extension, lymph node metastasis, distant metastasis and patient mortality were not statistically different from those of TCVPTC. Additionally, PTC-TCF and TCVPTC were both associated with an increased risk for aggressive clinical courses as compared to classical PTC. The prevalence of BRAF mutation in PTC-TCF and TCVPTC was comparable and both were significantly higher than that in classical PTC. The present meta-analysis demonstrated that even a PTC comprising only 10% of TCs might be associated with a poor clinical outcome. Therefore, the proportions of PTC in PTC should be carefully estimated and reported even when the TC component is as little as 10%.https://ec.bioscientifica.com/view/journals/ec/7/12/EC-18-0333.xmlpapillary thyroid carcinomatall cell featuretall cellmeta-analysisreviewBRAFTERTprognosissurvivalaggressive |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Huy Gia Vuong Nguyen Phuoc Long Nguyen Hoang Anh Tran Diem Nghi Mai Van Hieu Le Phi Hung Tadao Nakazawa Ryohei Katoh Tetsuo Kondo |
spellingShingle |
Huy Gia Vuong Nguyen Phuoc Long Nguyen Hoang Anh Tran Diem Nghi Mai Van Hieu Le Phi Hung Tadao Nakazawa Ryohei Katoh Tetsuo Kondo Papillary thyroid carcinoma with tall cell features is as aggressive as tall cell variant: a meta-analysis Endocrine Connections papillary thyroid carcinoma tall cell feature tall cell meta-analysis review BRAF TERT prognosis survival aggressive |
author_facet |
Huy Gia Vuong Nguyen Phuoc Long Nguyen Hoang Anh Tran Diem Nghi Mai Van Hieu Le Phi Hung Tadao Nakazawa Ryohei Katoh Tetsuo Kondo |
author_sort |
Huy Gia Vuong |
title |
Papillary thyroid carcinoma with tall cell features is as aggressive as tall cell variant: a meta-analysis |
title_short |
Papillary thyroid carcinoma with tall cell features is as aggressive as tall cell variant: a meta-analysis |
title_full |
Papillary thyroid carcinoma with tall cell features is as aggressive as tall cell variant: a meta-analysis |
title_fullStr |
Papillary thyroid carcinoma with tall cell features is as aggressive as tall cell variant: a meta-analysis |
title_full_unstemmed |
Papillary thyroid carcinoma with tall cell features is as aggressive as tall cell variant: a meta-analysis |
title_sort |
papillary thyroid carcinoma with tall cell features is as aggressive as tall cell variant: a meta-analysis |
publisher |
Bioscientifica |
series |
Endocrine Connections |
issn |
2049-3614 2049-3614 |
publishDate |
2018-11-01 |
description |
There are still ongoing debates as to which cut-off percentage of tall cell (TC) should be used to define tall cell variant (TCV) papillary thyroid carcinoma (PTC). In this meta-analysis, we aimed to investigate the clinicopathological significance of PTC with tall cell features (PTC-TCF, PTC with 10–50% of TCs) in comparison with classical PTC and TCVPTC (PTC with more than 50% of TCs) to clarify the controversial issue. Four electronic databases including PubMed, Web of Science, Scopus and Virtual Health Library were accessed to search for relevant articles. We extracted data from published studies and pooled into odds ratio (OR) and its corresponding 95% confidence intervals (CIs) using random-effect modeling. Nine studies comprising 403 TCVPTCs, 325 PTC-TCFs and 3552 classical PTCs were included for meta-analyses. Overall, the clinicopathological profiles of PTC-TCF including multifocality, extrathyroidal extension, lymph node metastasis, distant metastasis and patient mortality were not statistically different from those of TCVPTC. Additionally, PTC-TCF and TCVPTC were both associated with an increased risk for aggressive clinical courses as compared to classical PTC. The prevalence of BRAF mutation in PTC-TCF and TCVPTC was comparable and both were significantly higher than that in classical PTC. The present meta-analysis demonstrated that even a PTC comprising only 10% of TCs might be associated with a poor clinical outcome. Therefore, the proportions of PTC in PTC should be carefully estimated and reported even when the TC component is as little as 10%. |
topic |
papillary thyroid carcinoma tall cell feature tall cell meta-analysis review BRAF TERT prognosis survival aggressive |
url |
https://ec.bioscientifica.com/view/journals/ec/7/12/EC-18-0333.xml |
work_keys_str_mv |
AT huygiavuong papillarythyroidcarcinomawithtallcellfeaturesisasaggressiveastallcellvariantametaanalysis AT nguyenphuoclong papillarythyroidcarcinomawithtallcellfeaturesisasaggressiveastallcellvariantametaanalysis AT nguyenhoanganh papillarythyroidcarcinomawithtallcellfeaturesisasaggressiveastallcellvariantametaanalysis AT trandiemnghi papillarythyroidcarcinomawithtallcellfeaturesisasaggressiveastallcellvariantametaanalysis AT maivanhieu papillarythyroidcarcinomawithtallcellfeaturesisasaggressiveastallcellvariantametaanalysis AT lephihung papillarythyroidcarcinomawithtallcellfeaturesisasaggressiveastallcellvariantametaanalysis AT tadaonakazawa papillarythyroidcarcinomawithtallcellfeaturesisasaggressiveastallcellvariantametaanalysis AT ryoheikatoh papillarythyroidcarcinomawithtallcellfeaturesisasaggressiveastallcellvariantametaanalysis AT tetsuokondo papillarythyroidcarcinomawithtallcellfeaturesisasaggressiveastallcellvariantametaanalysis |
_version_ |
1725294457213943808 |